Medical specialists from Belgium tagged as investigators in clinical trials studying Hepatitis A

Total 9 results

Christophe Moreno, Prof.
Seen in:
- Brussels, CUB Hôpital Erasme
Trials:
- NCT05070364 (Principal Investigator)
Conditions:
- Hepatitis Delta Virus
Dana Busschotes, drs.
Seen in:
- Diepenbeek, Hasselt University
Trials:
- NCT04717856 (Sub-Investigator)
Conditions:
- Hepatitis C;
- Drug Use
Frederik Nevens
Seen in:
- Leuven, GSK Investigational Site
Trials:
- NCT03866187 (Principal Investigator)
Conditions:
- Hepatitis B, Chronic
Jan de Hoon
Seen in:
- Leuven, GSK Investigational Site
Trials:
- NCT05561673 (Principal Investigator)
Conditions:
- Hepatitis B
Jean-Pierre Mulkay
Seen in:
- Bruxelles, GSK Investigational Site
Trials:
- NCT03866187 (Principal Investigator)
Conditions:
- Hepatitis B, Chronic
Luc Lasser, Dr.
Seen in:
- Brussels, CHU Brugmann
Trials:
- NCT05070364 (Principal Investigator)
Conditions:
- Hepatitis Delta Virus
Stefan Bourgeois
Seen in:
- Antwerpen, GSK Investigational Site
Trials:
- NCT03866187 (Principal Investigator)
Conditions:
- Hepatitis B, Chronic
Thomas Vanwolleghem
Seen in:
- Antwerp, Edegem, University Hospital Antwerp
- Edegem, GSK Investigational Site
Trials:
- NCT05276297 (Principal Investigator)
- NCT03866187 (Principal Investigator)
- NCT05070364 (Principal Investigator)
Conditions:
- Hepatitis B, Chronic;
- Hepatitis Delta Virus

Clinical Trials on Hepatitis A

Boryung Pharmaceutical Co., Ltd

Completed

To Evaluate the Immunogenicity and Safety of Inactivated Hepatitis A Vaccine (VITHA-C)

Hepatitis A Vaccine

Korea, Republic of
Sanofi Pasteur, a Sanofi Company

Completed

Safety of Two Doses of Avaxim® 80U Pediatric (Inactivated Hepatitis A Vaccine) in Toddlers, Children and Adolescents

Hepatitis A | Hepatitis A Virus

China
Boryung Pharmaceutical Co., Ltd

Completed

To Evaluate the Immunogenicity and Safety of Inactivated Hepatitis A Vaccine (VITHA-A)

Hepatitis A Vaccine

Korea, Republic of
Merck Sharp & Dohme LLC

Completed

A Study of 2 Doses of VAQTA™ in Healthy Children 12 to 23 Months of Age (V251-069)

Hepatitis A Virus Infection
GlaxoSmithKline

Completed

This Study Will Evaluate the Persistence of Hepatitis A Antibodies, 8 Years and 10 Years Later, in Children Who Had Received Havrix at Selected Health Centres of Panama

Hepatitis A Vaccine

Panama
GlaxoSmithKline

Completed

Surveillance Study to Determine the Trends in Acute Hepatitis A Among Panamanian Children

Hepatitis | Acute Hepatitis A

Panama
Grifols Therapeutics LLC

Completed

Anti-Hepatitis A Virus, Pharmacokinetics, and Safety of Immune Globulin (Human) (GamaSTAN)

Anti-Hepatitis A Antibody Levels in Heathy Subjects

United States
Boryung Biopharma Co., Ltd.

Not yet recruiting

To Evaluate the Immunogenicity and Safety of Inactivated Hepatitis A Vaccine in Healthy Children Aged From 24mons-15yrs

Hepatitis A | Hep A

Korea, Republic of, Thailand
Merck Sharp & Dohme LLC

Completed

Concomitant Use of Hepatitis A Vaccine With Measles, Mumps, Rubella and Varicella Vaccine and Pneumococcal 7-Valent Conjugate Vaccine in Healthy 12-Month-Old Children (V251-067)

Hepatitis A Virus
University of Maryland, Baltimore
Alexandria University; MADAUS GmbH; The Egyptian Company for Blood Transfusion... and other collaborators

Terminated

Randomized Placebo-controlled Trial Evaluating the Safety and Efficacy of Silymarin Treatment in Patients With Acute Viral Hepatitis

Acute Hepatitis C | Acute Hepatitis B | Acute Hepatitis A | Acute Hepatitis E | Acute EBV Hepatitis | Acute CMV Hepatitis

Egypt

Medical specialists from Belgium tagged as investigators in clinical trials studying Hepatitis A

Clinical Trials on Hepatitis A

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Belarus

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations